The LeaderMed team’s expertise allows them to advance and obtain regulatory approvals for new drugs in China and the Asia-Pacific region faster than what can be secured in the U.S. and Europe.
In the China and Asia-Pacific markets our team members have led over 60 trials for innovative drugs; co-founded a CRO; led over 10 successful NDAs; and commercialized over $3 billion in global drug sales and medical devices, benefitting patients in over 50 countries.
Shared 56 years ago
2 views
Shared 56 years ago
140 views
Shared 56 years ago
194 views
Shared 56 years ago
198 views
Shared 56 years ago
176 views
Shared 56 years ago
65 views
Shared 56 years ago
57 views
Shared 56 years ago
1.6K views
Shared 56 years ago
219 views
Shared 56 years ago
95 views
UltraSculpt™ Launch at Wave Spa | Luxury Non-Invasive Body Sculpting at Wave Resort Long Branch NJ 💫
Shared 56 years ago
326 views
Shared 56 years ago
4K views
Shared 56 years ago
66 views
Shared 56 years ago
582 views
Shared 56 years ago
1.5K views
Shared 56 years ago
117 views
Shared 56 years ago
157 views
Shared 56 years ago
698 views
UltraSculpt’s Nobel miRNA Tech! 🏆 Patented 5 Years Before Nobel Prize! 💡 #BeautyInnovation #Skincare
Shared 56 years ago
54 views
Shared 56 years ago
45 views
Shared 56 years ago
39 views
Shared 56 years ago
623 views
Shared 56 years ago
172 views